Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

Opposite changes in meteorin-like and oncostatin m levels are associated with metabolic improvements after bariatric surgery

International Journal of Obesity volume 42, pages 919–922 (2018)Cite this article

Subjects

Abstract

Bariatric surgery is currently the most effective therapy for type 2 diabetes. However, the mechanisms underlying its beneficial effects remain elusive. Here we studied the effects of bariatric surgery on circulating meteorin-like (Metrnl) and oncostatin m (OSM) levels, two hormones intimately linked to energy homeostasis. Metrnl and OSM levels were assessed at baseline, 6 and 12 months after laparoscopic sleeve gastrectomy (LSG) in 25 patients with obesity, as well as in 33 normal-weight controls. At baseline, patients with obesity showed lower Metrnl and higher OSM levels compared to controls. LSG increased Metrnl and decreased OSM levels, in correlation to improvements in glucose and lipid homeostasis. Our data indicate that LSG conversely modulated Metrnl and OSM levels, and suggest that a dual approach modulating these two molecules might provide a novel strategy for obesity and type 2 diabetes treatment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Aron-Wisnewsky J, Tordjman J, Poitou C, Darakhshan F, Hugol D, Basdevant A et al. Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab 2009; 94: 4619–4623.

    Article  CAS  Google Scholar 

  2. Pontiroli AE, Morabito A . Long-term prevention of mortality in morbid obesity through bariatric surgery: a systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg 2011; 253: 484–487.

    Article  Google Scholar 

  3. Poitou C, Perret C, Mathieu F, Truong V, Blum Y, Durand H et al. Bariatric surgery induces disruption in inflammatory signaling pathways mediated by immune cells in adipose tissue: a RNA-Seq study. PLoS One 2015; 10: e0125718.

    Article  Google Scholar 

  4. Cummings DE, Cohen RV . Bariatric/metabolic surgery to treat type 2 diabetes in patients with a BMI <35 kg/m2. Diabetes Care 2016; 39: 924–933.

    Article  Google Scholar 

  5. Vijgen GH, Bouvy ND, Teule GJ, Brans B, Hoeks J, Schrauwen P et al. Increase in brown adipose tissue activity after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 2012; 97: E1229–E1233.

    Article  CAS  Google Scholar 

  6. Rachid B, van de Sande-Lee S, Rodovalho S, Folli F, Beltramini GC, Morari J et al. Distinct regulation of hypothalamic and brown/beige adipose tissue activities in human obesity. Int J Obes (Lond) 2015; 39: 1515–1522.

    Article  CAS  Google Scholar 

  7. Rao RR, Long JZ, White JP, Svensson KJ, Lou J, Lokurkar I et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell 2014; 5: 1279–1291.

    Article  Google Scholar 

  8. Sánchez-Infantes D, Cereijo R, Peyrou M, Piquer-Garcia I, Stephens JM, Villarroya F . Oncostatin m impairs brown adipose tissue thermogenic function and the browning of subcutaneous white adipose tissue. Obesity (Silver Spring) 2017; 25: 85–93.

    Article  Google Scholar 

  9. Sanchez-Infantes D, White UA, Elks CM, Morrison RF, Gimble JM, Considine RV et al. Oncostatin m is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes. J Clin Endocrinol Metab 2014; 99: E217–E225.

    Article  CAS  Google Scholar 

  10. Li ZY, Song J, Zheng SL, Fan MB, Guan YF, Qu Y et al. Adipocyte Metrnl antagonizes insulin resistance through PPARγ signaling. Diabetes 2015; 64: 4011–4022.

    Article  CAS  Google Scholar 

  11. Albiero M, Poncina N, Ciciliot S, Cappellari R, Menegazzo L, Ferraro F et al. Bone marrow macrophages contribute to diabetic stem cell mobilopathy by producing oncostatin M. Diabetes 2015; 64: 2957–2968.

    Article  CAS  Google Scholar 

  12. West NR, Hegazy AN, Owens BM, Bullers SJ, Linggi B, Buonocore S et al. Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. Nat Med 2017; 23: 579–589.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Samples from patients included in this study were provided by the IGTP HUGTP Biobank integrated in the Spanish National Biobanks Network of Instituto de Salud Carlos III (PT13/0010/0009) and they were processed following standard operating procedures with the appropriate approval of the Ethical and Scientific Committees. DS-I is an Investigator of the Miguel Servet Fund from Carlos III National Institute of Health, Spain. AP is a Ramón y Cajal researcher. This study was supported by Instituto de Salud Carlos III, and by the Fondo Europeo de Desarrollo Regional (FEDER), Madrid, Spain (CP15/00106), and by SAF2014-55702-JIN from the Ministerio de Ciencia e Innovación, Spain, co-financed by the European Regional Development Fund (ERDF).

Author information

Author notes

  1. S Pellitero, I Piquer-Garcia and G Ferrer-Curriu: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Endocrinology and Nutrition, Germans Trias i Pujol Research Institute, Barcelona, Spain and CIBER Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Spain

    S Pellitero, I Piquer-Garcia, R Puig, E Martínez, M Puig-Domingo & D Sánchez-Infantes

  2. Department of Biochemistry and Molecular Biomedicine. Institut de Biomedicina de la Universitat de Barcelona (IBUB), Universitat de Barcelona, Barcelona, Spain

    G Ferrer-Curriu, F Villarroya & A Planavila

  3. CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Spain

    G Ferrer-Curriu, F Villarroya & A Planavila

  4. Department of Surgery, Germans Trias i Pujol Research Institute, Barcelona, Spain

    P Moreno & J Tarascó

  5. Metabolic and Bariatric Surgery Unit, EAC-BS Center of Excellence, Vall d'Hebron University Hospital, Barcelona, Spain

    J Balibrea

  6. Endocrinology Department, Institut de Recerca Sant Joan de Déu, Barcelona, Spain

    C Lerin

Authors
  1. S Pellitero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I Piquer-Garcia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G Ferrer-Curriu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R Puig
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P Moreno
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J Tarascó
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J Balibrea
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. C Lerin
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M Puig-Domingo
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. F Villarroya
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. A Planavila
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. D Sánchez-Infantes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to A Planavila or D Sánchez-Infantes.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on International Journal of Obesity website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pellitero, S., Piquer-Garcia, I., Ferrer-Curriu, G. et al. Opposite changes in meteorin-like and oncostatin m levels are associated with metabolic improvements after bariatric surgery. Int J Obes 42, 919–922 (2018). https://doi.org/10.1038/ijo.2017.268

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2017.268

This article is cited by

Search

Advanced search

Quick links